Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium

Directors

Lori Daniels, MD, MAS, FACC, FAHA

COURSE DIRECTOR

Professor of Medicine
Director, Coronary Care Unit
Division of Cardiology
UC San Diego
La Jolla, CA

Christopher deFilippi, MD, FACC

Lori Daniels, MD, MAS, FACC, FAHA

COURSE CO-DIRECTOR

Professor of Medicine & Pathology

Co-Director of Clinical Core Research Laboratory

University of Maryland School of Medicine

Director of Cardiovascular and Biomarker Research University of Maryland Institute for Health Computing

Baltimore, MD

SYMPOSIUM OVERVIEW

Topics cover state-of-the-art application of biomarkers in the following clinical categories:

Current standards/guidelines for clinical biomarker use across screening, prevention, diagnosis and management.
High-sensitivity cardiac troponin in acute chest pain: Type 1 vs Type 2 MI, injury vs infarction, ED pathways, point-of-care whole-blood testing, and alignment with the Universal Definition of MI.
Troponin biology and analytics that impact interpretation (macro-troponin, autoantibodies, fragments, non-necrotic release) and practical fixes for pitfalls.
Heart failure and cardiorenal biomarkers to guide phenotyping, optimize GDMT, and support adherence.
Biomarker-guided prevention: ED interventions, early detection and risk reduction in diabetes.
Screening & precision prevention: Lp(a) emergence, population screening strategies, SMuRF-less risk, and age-aware interpretation in late life.
Inflammation & novel targets: CRP/IL-6 axis across diabetes/CVD/CKD and the therapeutic potential of GDF-15.
Clinical studies and practice evolution: biomarker-informed qualification/enrichment, surrogate endpoints, and outcome adjudication; emerging technologies from outpatient to critical care.

TARGET AUDIENCE

The target audience for this activity includes Cardiologists, Internists, Primary Care Physicians, Emergency Medicine Physicians, Clinical Laboratorians, Nursing Professionals and Allied Healthcare Professionals.

CALL FOR ABSTRACTS

The Biomarkers Symposium invites you to submit abstracts for review! Please navigate to the "Abstracts" page under MORE for all of the pertinent information.

May 15, 2026

Directors

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Christopher deFilippi, MD, FACC

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Join us for the Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium

SYMPOSIUM OVERVIEW

TARGET AUDIENCE

CALL FOR ABSTRACTS

May 15, 2026

Directors

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Christopher deFilippi, MD, FACC

Lori Daniels, MD, MAS, FACC, FAHA

Lori Daniels, MD, MAS, FACC, FAHA

Join us for the Biomarkers and Personalized Medicine in Cardiovascular Disease Symposium

SYMPOSIUM OVERVIEW

TARGET AUDIENCE

CALL FOR ABSTRACTS

SIGN UP TO RECEIVE EMAILS

This website uses cookies.